US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar Oct 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Amrize, Dexcom, and Lennar, on Thursday.
HIGHLIGHTS
* Amrize AMRZ.N: Barclays initiates coverage with equal-weight rating; PT $55 |
* Dexcom DXCM.O: RBC ups PT to $105 from $90 |
* Lennar LEN.N: Morgan Stanley initiates coverage with underweight rating; PT $65 |
* Levi Strauss & Co LEVI.N: Jefferies cuts PT to $25 from $27 |
* Synopsys SNPS.O: Deutsche Bank ups PT to $640 from $590 |
The following is a summary of research actions on US companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Agree Realty ADC.N: RBC cuts PT to $73 from $82 |
* AIG AIG.N: BofA Global Research cuts price objective to $88 from $92 |
* Albemarle ALB.N: Mizuho cuts PT to $130 from $140 |
* Allstate Corp ALL.N: BofA Global Research raises price objective to $336 from $334 |
* American Airlines AAL.O: Jefferies cuts target price to $12 from $15 |
* Amrize AMRZ.N: Barclays initiates coverage with equal-weight rating; PT $55 |
* Amrize AMRZ.N: Citigroup cuts target price to $50 from $58 |
* Apple AAPL.O: Morgan Stanley cuts target price to $355 from $360 |
* Atmos Energy ATO.N: Jefferies cuts PT to $167 from $173 |
* Atossa Therapeutics ATOS.O: Ascendiant Capital Markets ups PT to $25 from $24 |
* Axogen AXGN.O: Truist Securities cuts target price to $53 from $60 |
* Banc of California BANC.N: Piper Sandler cuts PT to $22 from $23 |
* Bank of America BAC.N: Truist Securities cuts target price to $62 from $65 |
* Bank of Hawaii BOH.N: Piper Sandler cuts PT to $78 from $85 |
* Bank of Marin Bancorp BMRC.O: Piper Sandler cuts PT to $29 from $30 |
* Banner Corp BANR.O: Piper Sandler cuts PT to $71 from $74 |
* BJ's Restaurants BJRI.O: Mizuho raises target price to $76 from $74 |
* BJ's Restaurants BJRI.O: Mizuho raises to outperform from neutral |
* Blackstone BX.N: HSBC cuts PT to $122 from $135 |
* Blackstone Digital Infrastructure Trust BXDC.N: Moffettnathanson cuts PT to $20 from $21 |
* Brown & Brown BRO.N: JP Morgan ups PT to $83 from $80 |
* Cal-Maine Foods CALM.O: Stephens cuts target price to $70 from $80 |
* Carmax KMX.N: Barclays raises target price to $67 from $61 |
* Carmax KMX.N: Stephens ups PT to $81 from $74 |
* Carnival Corporation CCL.N: Citigroup cuts target price to $35 from $37 |
* Cigna CI.N: Jefferies cuts PT to $288 from $307 |
* Cincinnati Financial Corporation CINF.O: BofA Global Research cuts price objective to $187 from $193 |
* City Holding Co CHCO.O: KBW ups PT to $145 from $135 |
* Civeo CVEO.N: Northland Capital initiates coverage with outperform rating; PT $42 |
* Clorox CLX.N: TD Cowen cuts PT to $85 from $90 |
* Compass Group CPG.L: Deutsche Bank cuts PT to $35 from $40 |
* Conagra Brands CAG.N: Bernstein cuts target price to $11 from $12 |
* Conagra Brands CAG.N: TD Cowen cuts target price to $13 from $14 |
* Connect Biopharma Holdings Ltd CNTB.O: BTIG cuts PT to $5 from $10 |
* CRH Plc CRH.N: Citigroup cuts target price to $106 from $122 |
* Customers Bancorp CUBI.N: JP Morgan cuts PT to $92 from $96 |
* D.R. Horton DHI.N: Morgan Stanley initiates coverage with equal weight rating |
* D.R. Horton DHI.N: Morgan Stanley initiates coverage with target price $151 |
* Delta Air Lines DAL.N: Jefferies cuts target price to $95 from $110 |
* Dexcom DXCM.O: RBC ups PT to $105 from $90 |
* Dick's Sporting Goods DKS.N: Truist Securities cuts PT to $128 from $135 |
* Digital Turbine APPS.O: RBC initiates coverage with outperform rating; PT $15 |
* Dow DOW.N: Mizuho cuts PT to $32 from $35 |
* Draftkings DKNG.O: BTIG cuts target price to $25 from $30 |
* Dynatrace DT.N: UBS raises target price to $74 from $65 |
* E.L.F. Beauty ELF.N: Raymond James raises PT to $117 from $100 |
* Eagle Materials Inc EXP.N: Citigroup cuts target price to $190 from $232 |
* Eastman Chemical Co EMN.N: Mizuho cuts PT to $80 from $85 |
* Element Solutions ESI.N: Mizuho cuts PT to $42 from $45 |
* Enliven Therapeutics ELVN.O: JP Morgan starts coverage with overweight rating; PT $75 |
* EOG Resources EOG.N: JP Morgan raises target price to $164 from $151 |
* Ethos Technologies LIFE.O: JP Morgan cuts to neutral from overweight |
* Euronet Worldwide EEFT.O: Northland Capital cuts target price to $85 from $90 |
* Expeditors International of Washington EXPD.N: Baird ups PT to $200 from $190 |
* Factset FDS.N: BMO raises target price to $300 from $282 |
* Factset FDS.N: Deutsche Bank raises target price to $301 from $299 |
* Factset FDS.N: Stifel raises target price to $292 from $254 |
* First Business Financial Services FBIZ.O: Raymond James assumes coverage with outperform rating |
* First Business Financial Services FBIZ.O: Raymond James assumes coverage with PT $75 |
* First Citizens Bancshares FCNCA.O: JP Morgan cuts PT to $2300 from $2450 |
* First Hawaiian FHB.O: JP Morgan cuts PT to $29 from $30 |
* First Hawaiian FHB.O: JP Morgan raises to neutral from underweight |
* First Hawaiian FHB.O: Piper Sandler cuts PT to $27 from $30 |
* Flagstar Bank Na FLG.N: JP Morgan cuts PT to $14 from $15.50 |
* Flutter Entertainment Plc FLUT.N: BTIG cuts PT to $110 from $113 |
* Forbright FRBT.O: JP Morgan cuts PT to $22 from $23 |
* Forbright FRBT.O: JP Morgan raises to overweight from neutral |
* Freshpet FRPT.O: Needham initiates coverage with hold rating |
* Gaming and Leisure Properties GLPI.O: RBC cuts PT to $44 from $52 |
* Getty Realty GTY.N: RBC cuts PT to $30 from $36 |
* Globus Medical GMED.N: RBC cuts PT to $85 from $115 |
* Goosehead Insurance GSHD.O: JP Morgan cuts PT to $60 from $68 |
* Harmony Biosciences HRMY.O: Deutsche Bank ups PT to $42 from $39 |
* Hewlett Packard Enterprise HPE.N: Barclays ups PT to $83 from $79 |
* Hewlett Packard Enterprise HPE.N: Citigroup raises PT to $92 from $76 |
* Hewlett Packard Enterprise HPE.N: Morgan Stanley ups PT to $72 from $67 |
* Hewlett Packard Enterprise HPE.N: Piper Sandler ups PT to $70 from $57 |
* Hewlett Packard Enterprise HPE.N: Truist Securities ups PT to $75 from $70 |
* Hewlett Packard Enterprise Company HPE.N: UBS raises PT to $66 from $59 |
* Hillman Solutions HLMN.O: Canaccord Genuity cuts PT to $13 from $14 |
* Hub Group HUBG.O: Stifel raises to hold from sell |
* Immunome IMNM.O: Stifel initiates coverage with hold rating; PT $24 |
* Inspire Medical Systems INSP.N: RBC ups PT to $75 from $60 |
* Italy'S Prysmian PRY.MI: Kepler Cheuvreux ups PT to EUR 155 from EUR 151 |
* Jabil JBL.N: Barclays cuts target price to $378 from $426 |
* Jabil JBL.N: JP Morgan ups PT to $430 from $425 |
* KB Home KBH.N: Morgan Stanley starts coverage with underweight rating; PT $39 |
* KKR & Co KKR.N: HSBC cuts PT to $115 from $121 |
* Kratos Defense & Security Solutions KTOS.O: Jefferies cuts PT to $68 from $80 |
* Kura Oncology KURA.O: JP Morgan starts coverage with overweight rating; PT $30 |
* Lam Research LRCX.O: B. Riley raises target price to $390 from $350 |
* Lennar LEN.N: Morgan Stanley initiates coverage with underweight rating; PT $65 |
* Levi Strauss & Co LEVI.N: Jefferies cuts PT to $25 from $27 |
* Levi Strauss & Co LEVI.N: Stifel cuts target price to $27 from $28 |
* Liquidia LQDA.O: BTIG cuts to neutral from buy |
* Liquidia LQDA.O: Jefferies cuts PT to $45 from $115 |
* Liquidia LQDA.O: Needham cuts PT to $72 from $110 |
* Liquidia LQDA.O: Raymond James cuts target price to $53 from $106 |
* Liquidia LQDA.O: Raymond James cuts to outperform from strong buy |
* Marsh & Mclennan Companies MRSH.N: JP Morgan ups PT to $215 from $212 |
* Martin Marietta Materials MLM.N: Citigroup cuts PT to $610 from $690 |
* Merck & Co MRK.N: Jefferies ups PT to $177 from $175 |
* Micron Technology MU.O: D.A. Davidson ups PT to $2100 from $2000 |
* Micron Technology MU.O: Mizuho raises target price to $1400 from $1300 |
* Micron Technology MU.O: Rosenblatt Securities ups PT to $1900 from $1500 |
* Monte Rosa Therapeutics GLUE.O: H.C. Wainwright initiates coverage with PT $25 |
* Monte Rosa Therapeutics GLUE.O: H.C. Wainwright initiates coverage with buy rating |
* National Bank Holdings Corp NBHC.N: Piper Sandler cuts PT to $49 from $51 |
* National Energy Services Reunited NESR.O: BMO initiates coverage with outperform rating |
* National Energy Services Reunited NESR.O: BMO initiates coverage with PT $39 |
* NNN REIT NNN.N: RBC cuts PT to $42 from $47 |
* NVR NVR.N: Morgan Stanley initiates coverage with underweight rating; PT $5058 |
* Old National Bancorp ONB.O: JP Morgan cuts PT to $30 from $32 |
* Orchestra Biomed Holdings OBIO.O: Piper Sandler ups PT to $12 from $10 |
* Ormat Technologies ORA.N: UBS cuts target price to $100 from $157 |
* Ormat Technologies ORA.N: UBS cuts to neutral from buy |
* PBF Energy PBF.N: JP Morgan raises target price to $89 from $83 |
* Pepsico PEP.O: Barclays cuts target price to $133 from $142 |
* Pinnacle Financial Partners PNFP.N: JP Morgan cuts PT to $115 from $120 |
* Pinnacle West Capital PNW.N: Barclays cuts PT to $94 from $108 |
* PNC Financial Services PNC.N: Truist Securities cuts PT to $252 from $264 |
* preferred Bank PFBC.O: Piper Sandler ups PT to $120 from $115 |
* Pultegroup PHM.N: Morgan Stanley initiates coverage with equal weight rating |
* Pultegroup PHM.N: Morgan Stanley initiates coverage with PT $128 |
* Qnity Electronics Q.N: Mizuho cuts PT to $160 from $180 |
* Realty Income O.N: RBC cuts PT to $60 from $70 |
* Regeneron Pharmaceuticals REGN.O: Argus Research raises to buy from hold |
* Rogers ROG.N: B. Riley raises target price to $225 from $200 |
* Sable Offshore SOC.N: Roth MKM cuts PT to $10 |
* Sagimet Biosciences SGMT.O: Oppenheimer raises target price to $38 from $33 |
* Sagimet Biosciences SGMT.O: Oppenheimer ups PT to $38 from $33 |
* Semtech SMTC.O: Oppenheimer raises target price to $225 from $200 |
* Semtech SMTC.O: Oppenheimer ups PT to $225 from $200 |
* Sintx Technologies SINT.O: Ascendiant Capital Markets ups PT to $12.50 from $12 |
* Solstice Advanced Materials SOLS.O: Mizuho cuts PT to $65 from $70 |
* Southstate Bank Corp SSB.N: JP Morgan cuts PT to $120 from $125 |
* Southwest Airlines Co LUV.N: Jefferies cuts target price to $41 from $46 |
* Spyre Therapeutics SYRE.O: Jefferies ups PT to $129 from $126 |
* Spyre Therapeutics SYRE.O: Jonestrading raises target price to $130 from $121 |
* Summit Therapeutics SMMT.O: Barclays raises PT to $20 from $18 |
* Synopsys SNPS.O: Deutsche Bank raises target price to $640 from $590 |
* Synopsys SNPS.O: Deutsche Bank ups PT to $640 from $590 |
* Synopsys SNPS.O: Rosenblatt Securities raises target price to $620 from $575 |
* Texas Capital Bancshares TCBI.O: JP Morgan cuts PT to $100 from $110 |
* the Baldwin Insurance Group BWIN.O: JP Morgan cuts to neutral from overweight |
* the Baldwin Insurance Group BWIN.O: JP Morgan ups PT to $32 from $30 |
* the Progressive Corporation PGR.N: BofA Global Research raises price objective to $314 from $302 |
* The Vita Coco Company COCO.O: Oppenheimer initiates coverage with PT $70 |
* The Vita Coco Company COCO.O: Oppenheimer initiates coverage with outperform rating |
* The Williams Companies WMB.N: Barclays reinstates coverage with overweight rating |
* The Williams Companies WMB.N: Barclays reinstates coverage with PT $82 |
* Titan America SA TTAM.N: Citigroup cuts target price to $18 from $21 |
* Toll Brothers TOL.N: Morgan Stanley starts coverage with overweight rating; PT $159 |
* Travelers TRV.N: BofA Global Research cuts price objective to $301 from $307 |
* Trico Bancshares TCBK.O: Piper Sandler cuts PT to $56.5 from $63 |
* TWFG TWFG.O: JP Morgan cuts PT to $26 from $28 |
* U.S. Bancorp USB.N: Truist Securities cuts target price to $67 from $69 |
* UMB Financial UMBF.O: JP Morgan cuts PT to $160 from $180 |
* United Airlines UAL.O: Jefferies cuts target price to $134 from $155 |
* United Therapeutics UTHR.O: BTIG raises to buy from neutral |
* Valley National Bancorp VLY.O: JP Morgan cuts PT to $15.50 from $17 |
* Valvoline VVV.N: Citigroup cuts target price to $34 from $41 |
* VICI Properties VICI.N: RBC cuts PT to $26 from $29 |
* Vicor VICR.O: Needham raises target price to $350 from $320 |
* Vulcan Materials Co VMC.N: Citigroup cuts target price to $300 from $350 |
* W. R. Berkley Corporation WRB.N: BofA Global Research cuts price objective to $66 from $68 |
* W.P. Carey WPC.N: RBC cuts PT to $67 from $77 |
* Wafd WAFD.O: Piper Sandler cuts PT to $32 from $36 |
* Warner Music Group WMG.O: UBS raises target price to $43 from $42 |
* Wells Fargo WFC.N: Truist Securities raises target price to $95 from $94 |
* Western Alliance Ban WAL.N: JP Morgan cuts PT to $90 from $93 |
* Westlake Corp WLK.N: Mizuho cuts PT to $72 from $88 |
* Westlake Corp WLK.N: Truist Securities cuts target price to $90 from $104 |
* Whitehawk Therapeutics WHWK.O: Stifel initiates coverage with buy rating; PT $9 |
* Zenas Biopharma ZBIO.O: Citigroup raises target price to $48 from $41 |
* Zions Bancorp National Association ZION.O: JP Morgan cuts PT to $65 from $75 |
* Zions Bancorp National Association ZION.O: Piper Sandler cuts PT to $68 from $71 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Element Solutions
See all newsElement Solutions Inc reports results for the quarter ended September 30 - Earnings Summary
Element Solutions Q3 sales jump 52% on electronics demand, acquisitions impact
Brief: Element Solutions Q3 Sales USD 995.3 Million Vs. IBES Estimate USD 957.9 Million
Starboard's Smith unveils stake in Solstice, presses for improvements (updated)
Starboard's Smith unveils stake in Solstice, presses for improvements